Mahmoud Haghighat1, Mozhgan Moghtaderi2, Shirin Farjadian3. 1. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 3. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract
BACKGROUND: Familial Mediterranean fever (FMF) is an autosomal recessive genetic disorder characterized by recurrent episodes of self-limited fever and serosal tissues inflammation. METHODS: To evaluate clinical symptoms and common genetic mutations in southwestern Iranian patients with FMF, 20 unrelated patients were enrolled in this study based on clinical criteria. A panel of 12 common MEFV gene mutations was tested. RESULTS: The most frequent clinical presentations of the patients were fever, colicky abdominal pain and arthritis. Eighteen patients responded completely to colchicine therapy. MEFV gene mutations were detected in only 40% of the patients. The most common mutation was E148Q, detected in five patients (25%). The V726A, M694V and P369S mutations were each observed in one patient. CONCLUSIONS: Although none of the 12 mutations we included in our test panel was detected in 60% of our patients, all of them had FMF symptoms and responded well to colchicine. MEFV full gene sequencing analysis in these patients may lead to finding new mutations in southwestern Iranian FMF patients which would be helpful in designing a local diagnostic kit.
BACKGROUND:Familial Mediterranean fever (FMF) is an autosomal recessive genetic disorder characterized by recurrent episodes of self-limited fever and serosal tissues inflammation. METHODS: To evaluate clinical symptoms and common genetic mutations in southwestern Iranian patients with FMF, 20 unrelated patients were enrolled in this study based on clinical criteria. A panel of 12 common MEFV gene mutations was tested. RESULTS: The most frequent clinical presentations of the patients were fever, colicky abdominal pain and arthritis. Eighteen patients responded completely to colchicine therapy. MEFV gene mutations were detected in only 40% of the patients. The most common mutation was E148Q, detected in five patients (25%). The V726A, M694V and P369S mutations were each observed in one patient. CONCLUSIONS: Although none of the 12 mutations we included in our test panel was detected in 60% of our patients, all of them had FMF symptoms and responded well to colchicine. MEFV full gene sequencing analysis in these patients may lead to finding new mutations in southwestern Iranian FMFpatients which would be helpful in designing a local diagnostic kit.
Authors: E Yilmaz; S Ozen; B Balci; A Duzova; R Topaloglu; N Besbas; U Saatci; A Bakkaloglu; M Ozguc Journal: Eur J Hum Genet Date: 2001-07 Impact factor: 4.246
Authors: Hasan A Majeed; Mohammed El-Khateeb; Hatem El-Shanti; Zaid Abu Rabaiha; Marwan Tayeh; Dana Najib Journal: Semin Arthritis Rheum Date: 2005-06 Impact factor: 5.532
Authors: Amira S Sabbagh; Mona Ghasham; Rabab Abdel Khalek; Layal Greije; Dina M R Shammaa; Ghazi S Zaatari; Rami A R Mahfouz Journal: Mol Biol Rep Date: 2007-06-14 Impact factor: 2.316
Authors: Malik Ejder Yildirim; Hande Kucuk Kurtulgan; Ozturk Ozdemir; Hasan Kilicgun; Didem S Aydemir; Burak Baser; Ilhan Sezgin Journal: Ann Saudi Med Date: 2019-12-05 Impact factor: 1.526